Akari Therapeutics is a Biotech company based in Tampa, FL. It has raised $8.7M in total funding. Latest round: Seed.
Akari Therapeutics funding overview
Akari Therapeutics is a Biotech company based in Tampa, FL. Akari Therapeutics has raised $8.7M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Seed announced in February 2025. The round record for Akari Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include CARMA FUND, RV Invest, High-Tech Gründerfonds, MP Beteiligungs GmbH, Hessen Kapital I, Bruker Invest. 6 distinct backers are named across the disclosed rounds.
Akari Therapeutics at a glance
Total raised
$8.7M
Latest round
Seed
Latest round date
February 2025
Industry
Biotech
Headquarters
Tampa, FL
Notable investors
CARMA FUND, RV Invest, High-Tech Gründerfonds, MP Beteiligungs GmbH, Hessen Kapital I, Bruker Invest
Frequently asked about Akari Therapeutics funding
How much has Akari Therapeutics raised?
Akari Therapeutics has raised $8.7M in total disclosed funding across the rounds on record.
Who has invested in Akari Therapeutics?
CARMA FUND, RV Invest, High-Tech Gründerfonds, MP Beteiligungs GmbH, Hessen Kapital I, Bruker Invest are named among the investors backing Akari Therapeutics.
What was the latest Akari Therapeutics funding round?
The most recent disclosed round is a Seed, announced in February 2025.
Where is Akari Therapeutics based?
Akari Therapeutics is based in Tampa, FL.
What sector does Akari Therapeutics operate in?
Akari Therapeutics is tracked under Biotech from Tampa, FL, with $8.7M in disclosed funding.
When did Akari Therapeutics last raise?
The last disclosed Akari Therapeutics round closed in February 2025 at Seed.
Akari Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Tampa below to benchmark round size and investor mix.
